Related references
Note: Only part of the references are listed.Immune Response Induced by SARS-CoV-2 Vaccines in Patients With Inflammatory Bowel Disease Under Biologic Therapy
Isabel Garrido et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls
Freddy Caldera et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
Alexis Maillard et al.
BLOOD (2022)
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
Sarah Frey et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation
Raffi Lev-Tzion et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination
Paris Charilaou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany
Johanna Maria Classen et al.
DIGESTIVE DISEASES (2022)
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
Andrea Becerril-Gaitan et al.
EUROPEAN JOURNAL OF CANCER (2022)
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Muhammad Khan et al.
GASTROENTEROLOGY (2022)
ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
Karin Cerna et al.
GASTROENTEROLOGY (2022)
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
Hadar Edelman-Klapper et al.
GASTROENTEROLOGY (2022)
SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
Joshua Quan et al.
GASTROENTEROLOGY (2022)
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy
Zahra Jama Shire et al.
GUT (2022)
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study
Karin Cerna et al.
INFLAMMATORY BOWEL DISEASES (2022)
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID
Kimberly N. Weaver et al.
INFLAMMATORY BOWEL DISEASES (2022)
P677 Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry
E Zacharopoulou et al.
Journal of Crohns & Colitis (2022)
P417 Seroconversion after COVID-19 Vaccination in Inflammatory Bowel Disease Patients
M Horvath et al.
Journal of Crohns & Colitis (2022)
P330 Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination
T Knezevic et al.
Journal of Crohns & Colitis (2022)
DOP24 Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim analyses of the J-COMBAT trial
K Watanabe et al.
Journal of Crohns & Colitis (2022)
P588 T cell response to SARS-CoV-2 mRNA vaccines by an interferon-gamma release immunoassay in patients with Inflammatory Bowel disease receiving anti-TNF and thiopurine treatment
L F Mayorga Ayala et al.
Journal of Crohns & Colitis (2022)
DOP27 Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study
A Volkers et al.
Journal of Crohns & Colitis (2022)
P235 The natural history of COVID-19 in vaccinated Inflammatory Bowel Disease patients
N Viazis et al.
Journal of Crohns & Colitis (2022)
P307 The effect of COVID-19 infection and vaccination in patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome
N Sciberras et al.
Journal of Crohns & Colitis (2022)
P092 Humoral and T cell responses to COVID-19 vaccination in IBD
E Zhang et al.
Journal of Crohns & Colitis (2022)
P685 Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel Diseases
M Kappelman et al.
Journal of Crohns & Colitis (2022)
P600 Serologic response to COVID-19 vaccines in IBD patients: a prospective study
M D Martin Arranz et al.
Journal of Crohns & Colitis (2022)
P444 COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort
K Farkas et al.
Journal of Crohns & Colitis (2022)
P606 Use of TNF-α-antagonists and systemic steroids is associated with attenuated immunogenicity against SARS-CoV-2 in fully vaccinated patients with Inflammatory Bowel Disease
A T Otten et al.
Journal of Crohns & Colitis (2022)
P605 Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study
K K Jørgensen et al.
Journal of Crohns & Colitis (2022)
OP21 COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab
J Alexander et al.
Journal of Crohns & Colitis (2022)
P040 Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy; Early results of the VARIATION study (VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON)
J Doherty et al.
Journal of Crohns & Colitis (2022)
P566 Humoral immune response to mRNA COVID-19 vaccine in Puerto Ricans with IBD does not differ between class of biologics
P López Marte et al.
Journal of Crohns & Colitis (2022)
P354 Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?
V Macedo Silva et al.
Journal of Crohns & Colitis (2022)
P244 COVID-19 vaccine does not increase the likelihood of disease exacerbation in IBD: results from a population-based study
R Lev Zion et al.
Journal of Crohns & Colitis (2022)
P313 Within, 6 months from COVID-19 BNT162b2 vaccine patients with Inflammatory Bowel Diseases treated with Anti-TNFα have significantly lower serologic responses
K M Rabinowitz et al.
Journal of Crohns & Colitis (2022)
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
Ital Nemet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2022)
COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution
Irving Levine et al.
GASTROENTEROLOGY (2022)
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
James L. Alexander et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
Richard Vollenberg et al.
BIOMEDICINES (2022)
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis
Anuraag Jena et al.
AUTOIMMUNITY REVIEWS (2022)
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease
Joelynn Dailey et al.
INFLAMMATORY BOWEL DISEASES (2022)
S805 SARS-CoV-2 Vaccine Antibody Response in Patients With IBD
Manuel A. Garza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
P058 Impact of Inflammatory Bowel Disease Treatment and Risk of Covid-19 Infection after Full Immunization: A Nationwide Analysis
Julton Tomanguillo Chumbe et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
S775 Seroprevalence of COVID-19 in Patients With Inflammatory Bowel Disease Under Biologic Treatment
Isabel Garrido et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease
Gil Y. Melmed et al.
ANNALS OF INTERNAL MEDICINE (2021)
Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis
Gursimran S. Kochhar et al.
INFLAMMATORY BOWEL DISEASES (2021)
Correlates of protection against SARS-CoV-2 in rhesus macaques
Katherine McMahan et al.
NATURE (2021)
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
Michael D. Kappelman et al.
GASTROENTEROLOGY (2021)
COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States
Yousaf Bashir Hadi et al.
GASTROENTEROLOGY (2021)
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis
Anupam Kumar Singh et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)
Impairment of CD4+T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn's Disease after COVID-19 Vaccination: A Twin Case
Fabiana Gil Melgaco et al.
VIRUSES-BASEL (2021)
The impact of SARS-CoV-2 variants on IBD management
Jonathan P. Segal et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
David Simon et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease
A. Al-Janabi et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
Serre-Yu Wong et al.
GASTROENTEROLOGY (2021)
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Nicholas A. Kennedy et al.
GUT (2021)
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies
Jacqueline D. Squire et al.
INFLAMMATORY BOWEL DISEASES (2021)
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
James L. Alexander et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies
Mohammad Shehab et al.
VACCINES (2021)
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 A Prospective Cohort Study
Parakkal Deepak et al.
ANNALS OF INTERNAL MEDICINE (2021)
BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign
Amir Ben-Tov et al.
GASTROENTEROLOGY (2021)
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease
Valeriya Pozdnyakova et al.
GASTROENTEROLOGY (2021)
Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
Nabeel Khan et al.
GASTROENTEROLOGY (2021)
Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
Elizabeth A. Spencer et al.
INFLAMMATORY BOWEL DISEASES (2021)
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
Emire Seyahi et al.
RHEUMATOLOGY INTERNATIONAL (2021)
The impact of SARS-CoV-2 variants on IBD management
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
Zachary Munn et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
